Emerging Tools and Technologies for Microbiome-Aware Drug Development.

Henry J. Haiser; David de Gruijl

doi:10.1002/cpt.70026

August 11, 2025

Emerging Tools and Technologies for Microbiome-Aware Drug Development.

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: Pharmacomicrobiomics emphasizes the significance of gut microbiota in influencing drug response.
KEY EVIDENCE: The research identifies biomarkers that could help mitigate differences in how individuals respond to medications.
APPROACH: The study integrates emerging mechanistic insights and new tools to develop microbiome-aware strategies.
SIGNIFICANCE: This research advances personalized medicine, offering tailored interventions to improve drug efficacy and safety.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Pharmacomicrobiomics explores the role of the gut microbiota in pharmacokinetics and pharmacodynamics, paving the way for new biomarkers and intervention strategies to reduce interindividual variability in drug response. Emerging mechanistic insights and tools enable microbiome-aware approaches as a promising new facet of personalized medicine.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Haiser et al. (2025) studied this question.

synapsesocial.com/papers/689e03e0d61984b91e13cd69 https://doi.org/10.1002/cpt.70026

View at Publisher

Ask AI

Bookmark

Share

Emerging Tools and Technologies for Microbiome-Aware Drug Development.

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Emerging Tools and Technologies for Microbiome-Aware Drug Development.

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading